Iconographies supplémentaires de l'article : Zoledronic acid for all patients with newly diagnosed multiple myeloma?

Evangelos Terpos; Meletios A Dimopoulos

Related publications

Letter2011

Zoledronic acid for all patients with newly diagnosed multiple myeloma?

Evangelos Terpos, Meletios A Dimopoulos

Article2018

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Meletios A Dimopoulos, Sebastian Grosicki, W Wiktor-Jędrzejczak, Hareth Nahi, Astrid Gruber, Markus Hansson, Neeraj Gupta, Catriona Byrne, Richard Labotka, Zhaoyang Teng, Huyuan Yang, Norbert Grząśko, Shaji Kumar

Article1993

Combination therapy with interferon‐dexamethasone for newly diagnosed patients with multiple myeloma

Meletios A Dimopoulos, Donna Weber, Kay Delasalle, Raymond Alexanian

Article2011

Deletion 17p in Unselected Newly Diagnosed Symptomatic Patients with Multiple Myeloma

Efstathios Kastritis, Evangelos Terpos, Μαρία Γκοτζαμανίδου, Μαρία Ρούσσου, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Dimitrios Christoulas, Dimitra Gika, Meletios A Dimopoulos

Article2024

Outcomes of Newly Diagnosed Multiple Myeloma Patients Requiring Dialysis

Despina Fotiou, Foteini Theodorakakou, Eirini Solia, Maria Gavriatopoulou, Vasiliki Spiliopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Erasmia Psimenou, Nikolaos Kanellias, Μαρία Ρούσσου, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis